Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: Implications for outpatient monitoring with B-type natriuretic peptide

This publication has 33 references indexed in Scilit:

• Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: implications for clinical trials
  Journal of the American College of Cardiology, 1999
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
  American Heart Journal, 1998
• Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators
  Published by Oxford University Press (OUP) ,1997
• Attenuation of Compensation of Endogenous Cardiac Natriuretic Peptide System in Chronic Heart Failure
  Circulation, 1997
• Brain natriuretic peptide predicts mortality in the elderly.
  Heart, 1997
• Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
  The American Journal of Cardiology, 1995
• Biochemistry of natriuretic peptides
  Journal of Internal Medicine, 1994
• Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group.
  Circulation, 1990
• Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
  Circulation, 1990
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984